Leveraging the Tumor Microenvironment for IO Therapy
PharmaTalkRadio8 Mar 2020

Leveraging the Tumor Microenvironment for IO Therapy

First recorded at the 4th annual IO Combinations 360° conference, this talk provided by Dr Kenneth Hance, GSK addresses agonistic strategies, T and NK cell redirection and the use of genetic/phenotypic assocations to identify novel target space in IO. To learn more about the upcoming IO Combinations 360° conference please visit, www.iocombinations360.com

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(461)

Populært innen Vitenskap

fastlegen
tingenes-tilstand
romkapsel
rss-nysgjerrige-norge
sinnsyn
forskningno
rekommandert
dekodet-2
liberal-halvtime
rss-paradigmepodden
fjellsportpodden
rss-rekommandert
tidlose-historier
jss
grunnstoffene
villmarksliv
hva-er-greia-med
vett-og-vitenskap-med-gaute-einevoll
nordnorsk-historie
aldring-og-helse-podden